These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 33230417)
1. SARS-CoV-2 and Iesa MAM; Osman MEM; Hassan MA; Dirar AIA; Abuzeid N; Mancuso JJ; Pandey R; Mohammed AA; Borad MJ; Babiker HM; Konozy EHE New Microbes New Infect; 2020 Nov; 38():100817. PubMed ID: 33230417 [TBL] [Abstract][Full Text] [Related]
2. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J Front Immunol; 2020; 11():1870. PubMed ID: 32983106 [TBL] [Abstract][Full Text] [Related]
3. Limited Recognition of Highly Conserved Regions of SARS-CoV-2. Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796 [TBL] [Abstract][Full Text] [Related]
4. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach. Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T Front Immunol; 2021; 12():692937. PubMed ID: 34497604 [TBL] [Abstract][Full Text] [Related]
13. Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Kalungi A; Kinyanda E; Akena DH; Kaleebu P; Bisangwa IM Front Immunol; 2021; 12():565625. PubMed ID: 33679730 [TBL] [Abstract][Full Text] [Related]
14. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of Hassan MM; Sharmin S; Hong J; Lee HS; Kim HJ; Hong ST Open Life Sci; 2021; 16(1):630-640. PubMed ID: 34222663 [TBL] [Abstract][Full Text] [Related]
15. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients. Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK mBio; 2019 Oct; 10(5):. PubMed ID: 31594821 [TBL] [Abstract][Full Text] [Related]
17. Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria. Belmonte M; Ganeshan H; Huang J; Belmonte A; Inoue S; Velasco R; Acheampong N; Ofori EA; Akyea-Mensah K; Frimpong A; Ennuson NA; Frempong AF; Kyei-Baafour E; Amoah LE; Edgel K; Peters B; Villasante E; Kusi KA; Sedegah M Vaccine; 2023 Feb; 41(6):1265-1273. PubMed ID: 36642628 [TBL] [Abstract][Full Text] [Related]
18. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population. Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L Front Immunol; 2024; 15():1357731. PubMed ID: 38784379 [TBL] [Abstract][Full Text] [Related]
19. Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas. Traoré A; Guindo MA; Konaté D; Traoré B; Diakité SA; Kanté S; Dembélé A; Cissé A; Incandela NC; Kodio M; Coulibaly YI; Faye O; Kajava AV; Pratesi F; Migliorini P; Papini AM; Pacini L; Rovero P; Errante F; Diakité M; Arevalo-Herrera M; Herrera S; Corradin G; Balam S Front Immunol; 2022; 13():856033. PubMed ID: 35585976 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]